Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer

导出原文传递

翻译打印收藏纠错

作者： Yu,K.-D. ^[1] ; Zhu,R. ^[2] ; Zhan,M. ^[3] ; Rodriguez,A.A. ^[4] ; Yang,W. ^[5] ; Wong,S. ^[6] ; Makris,A. ; Lehmann,B.D. ; Chen,X. ; Mayer,I. ; Pietenpol,J.A. ; Shao,Z.-M. ; Symmans,W.F. ; Chang,J.C.

作者单位： Department of Breast Surgery, Shanghai Cancer Center, Cancer Institute of Fudan University ^[1] Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, United States ^[2] Department of Systems Medicine and Bioengineering, Methodist Hospital Research Institute, Houston ^[3] Mount Vernon Hospital, London, United Kingdom ^[4] Methodist Hospital Cancer Center, Houston, TX 77050, United States ^[5] University of Texas MD Anderson Cancer Center, Houston, TX, United States ^[6]

发布时间 2013-12-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Clinical cancer research

2013年19卷10期

2723-2733页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer

Clinical cancer research

相似文献

Clinical cancer research

相关期刊

检索历史清除